34450-18-5

Basic information

• Product Name: 17-OCTADECYNOIC ACID
• Synonyms: 17-ODA;17-ODYA;17-OCTADECYNOIC ACID;ODYA;17-OCTADECYNOIC ACID \ CYTOCHROME P450 E;17-ODYA (17-Octadecynoic acid);Alkynyl Stearic Acid;DZIILFGADWDKMF-UHFFFAOYSA-N
• CAS NO: 34450-18-5
• Molecular Formula: C₁₈H₃₂O₂
• Molecular Weight: 280.45
• Product Categories: Cytochrome P450Enzyme Inhibitors by Enzyme;Cytochrome P450Unsaturated fatty acids and derivatives;A to;Arachidonic Acid Cascade;Enzyme Inhibitors;Monoenoic fatty acids;Others
• Mol File: 34450-18-5.mol

Chemical Properties

• Boiling Point: 400.8°Cat760mmHg
• Flash Point: 194.7°C
• Appearance: /
• Density: 0.922g/cm³
• Vapor Pressure: 1.52E-07mmHg at 25°C
• Refractive Index: 1.47
• Storage Temp.: Store at RT
• PKA: 4.78±0.10(Predicted)
• CAS DataBase Reference: 17-OCTADECYNOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 17-OCTADECYNOIC ACID(34450-18-5)
• EPA Substance Registry System: 17-OCTADECYNOIC ACID(34450-18-5)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 34450-18-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Applications:
17-octadecynoic acid is used as a pharmaceutical agent for inhibiting LTB4 ω-oxidase, which plays a crucial role in various inflammatory processes. By targeting this enzyme, 17-ODYA can potentially help in the treatment of conditions associated with inflammation.
Used in Research and Development:
In the field of research, 17-octadecynoic acid is used as a research tool for studying the post-translational acylation of proteins. Its alkynyl stearic acid structure allows for the application of Click Chemistry, enabling the identification and characterization of proteins that undergo this modification.
Used in Drug Delivery Systems:
Although not explicitly mentioned in the provided materials, 17-octadecynoic acid could potentially be used in drug delivery systems, similar to gallotannin, to improve its delivery, bioavailability, and therapeutic outcomes. This would require further research and development to explore its potential in this application.

Biological Activity

Potent suicide inhibitor of LTB 4 ω -hydroxylase.

Biochem/physiol Actions

17-Octadecynoic acid (7-ODYA) is an irreversible inhibitor of cytochrome P450 isozymes, that participates in long-chain fatty acid metabolism.

InChI:InChI=1/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h1H,3-17H2,(H,19,20)

Upstream product

• 506-24-1 Stearolic acid 
• 506-13-8 16-hydroxyhexadecanoic acid 
• 1120-32-7 stearolic acid methyl ester 
• 25456-04-6 methyl 9,10-dibromostearate 
• 84999-79-1 1-hydroxy octadec 11-yne 
• 112-80-1 cis-Octadecenoic acid 
• 112-79-8 Elaidic Acid 
• 19117-94-3 9,10-dibromooctadecanoic acid 
• 2536-36-9 16-iodohexadecanoic acid 
• 1216963-74-4 lithium acetylide-ethylenediamine complex 
• 112-62-9 Methyl oleate 
• 2861-49-6 n-Octadec-9-yn-1-ol 
• 21721-01-7 12-octadecyn-1-ol 
• 1611-56-9 1-Bromo-11-hydroxyundecane 

Downstream Products

• 149221-79-4 1,2-di-O-(17-octadecyn-1-ol)-3-benzyl-sn-glycerol 
• 871-70-5 octadecanedioic acid 
• 1391054-35-5 2,4-di(4'-methoxybenzylamino)-6-[2'-(17-octadecynoyloxy)ethylamino]-1,3,5-triazine 
• 2380-32-7 methyl 17-oxooctadecanoate 
• 149221-82-9 1,2-O-(17,19-hexatriacontadiyne-1,36-dioyl)-3-benzyl-sn-glycerol 

Relevant articles and documents

Preparation method of long-chain diacid

The invention provides a preparation method of long-chain diacid, which comprises the following steps of: (S1) carrying out an addition reaction on olefine acid or an ester derivative thereof serving as a raw material and liquid bromine to obtain dibromo carboxylic acid or an ester derivative thereof; (S2) carrying out an elimination reaction on the dibromo carboxylic acid or ester derivative thereof under the action of sodium amide to obtain alkynyl-terminated carboxylic acid or an ester derivative thereof; (S3) carrying out an addition reaction on the alkynyl-terminated carboxylic acid or the ester derivative thereof and diborane to obtain borane or boric acid containing carboxyl or ester group; and (S4) oxidizing the borane or boric acid to obtain long-chain diacid. According to the invention, olefine acid is used as a raw material, is easily available in source and low in price, so that the production cost of the product is very low; and meanwhile, the raw materials used in the synthesis process do not contain precious metals or other expensive reagents, so that the synthesis process is suitable for industrial amplification production, and the defect that the method in the prior art is not environment-friendly, not suitable for industrial production and high in preparation cost is overcome.

INSULIN CONJUGATES

The present invention relates to a conjugate comprising a sulfonamide of formula (I) and an active pharmaceutical ingredient such as an insulin analog comprising at least one mutation relative to the parent insulin, wherein the insulin analog comprises a mutation at position B16 which is substituted with a hydrophobic amino acid and/or a mutation at position B25 which is substituted with a hydrophobic amino acid. The present invention further relates to a sulfonamide of formula (A). Moreover, the present invention relates to an insulin analog comprising at least one mutation relative to the parent insulin.

Synthetic Fluorogenic Peptides Reveal Dynamic Substrate Specificity of Depalmitoylases

Palmitoylation is a post-translational modification involving the thioesterification of cysteine residues with a 16-carbon-saturated fatty acid. Little is known about rates of depalmitoylation or the parameters that dictate these rates. Here we report a modular strategy to synthesize quenched fluorogenic substrates for the specific detection of depalmitoylase activity and for mapping the substrate specificity of individual depalmitoylases. We demonstrate that human depalmitoylases APT1 and APT2, and TgPPT1 from the parasite Toxoplasma gondii, have distinct specificities that depend on amino acid residues distal to the palmitoyl cysteine. This information informs the design of optimal and non-optimal substrates as well as isoform-selective substrates to detect the activity of a specific depalmitoylase in complex proteomes. In addition to providing tools for studying depalmitoylases, our findings identify a previously unrecognized mechanism for regulating steady-state levels of distinct palmitoylation sites by sequence-dependent control of depalmitoylation rates. Amara et al. describe a method for preparing positional scanning libraries of fluorogenic palmitoylated peptide substrates. This allowed identification of residues that are distal to the palmitoylation site that impact turnover. This information allowed the design of substrates that are selective for a specific depalmitoylating enzyme.

Robust fluorescent detection of protein fatty-acylation with chemical reporters

Fatty-acylation of proteins in eukaryotes is associated with many fundamental cellular processes but has been challenging to study due to limited tools for rapid and robust detection of protein fatty-acylation in cells. The development of azido-fatty acid

Synthesis and thermotropic properties of macrocyclic lipids related to archaebacterial membranes

Macrocyclic phospholipids containing 32-44 ring atoms were synthesized by a route involving a high-temperature Glaser oxidation as the key step. These lipids are analogous to mammalian phospholipids except a single extra carboncarbon bond joins the chain termini. The new lipids offered, therefore, an opportunity to examine thermotropic properties of their membranes when the chains within a given molecule are unable to move independently of one another. It was concluded that chain "tethering" (a) raises the transition temperatures substantially for all but the shortest lipids, (b) lowers enthalpies of transition by, in part, reducing the number of gauche C-C linkages created during the melting process, and (c) lowers entropies of transition by impeding motional freedom within the liquid-crystalline phase. Molecular mechanics calculations on the macrocyclic lipids are described briefly.

Conversion of Oleic Acid to 17- and 18-Substituted Stearic Acid Derivatives by Way of the "Acetylene Zipper"

Stearolic acid (2) was prepared from oleic acid (1) and converted to 4, 5, and 7 by way of the "acetylene zipper" reaction.Compounds 5 and 7 were transformed to the (ω - 1) ketones 8 and 9 and dimerized by way of the Glaser coupling reaction to 11 and 12.At daylight, 12 polymerizes to a blue polymer. Key Words: Fatty acid / Oleic acid / Stearic acid, 17- and 18-substituted / Acetylene zipper

Synthesis and Evaluation of Radioiodinated (E)-18-Iodo-17-octadecenoic Acid as a Model Iodoalkenyl Fatty Acid for Myocardial Imaging

125I-labeled (E)-18-iodo-17-octadecenoic acid (13) has been prepared and evaluated in rats to determine the myocardial uptake and retention and degree of in vivo deiodination of this model iodovinyl-substituted fatty acid, which contains no structural perturbation to inhibit metabolism.This new agent was prepared by NaI-chloramine-T treatment of (17-carbomethoxyheptadec-1-en-1-yl)boronic acid (11) prepared by catecholborane treatment of methyl 17-octadecynoate (10), followed by basic hydrolysis to the free acid (13).The pivotal substrate, 17-octadecynoic acid (9), was prepared by two new routes .The 125I-labeled acid 13 showed high myocardial uptake (1 h, 1.90-2.28percent dose/g) with 45percent washout after 2 h but lower heart/blood ratios in comparison to analogues containing the tellurium heteroatom.Deiodination was low for the first 2 h after injection (2 h, 61percent dose/g).Excellent myocardial images were obtained in a dog with the 123I-labeled agent.